Funding profile · Autism services

Finni Health

One announced round, no Regulation D filing, and an asserted Series A with no number attached. The public capital record is thin next to the footprint the company describes.

$3.2MSeed announced June 12, 2023, led by General Catalyst
$3.95MTotal across four rounds per Tracxn, all labeled seed
$0Regulation D offerings on file with the SEC
1NPI enrolled by the operating entity, May 6, 2022

Data as of September 24, 2026. Company-reported and database-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2022 First outside money Not disclosed First Generation Capital; Entrepreneurs First Database
Winter 2023 Y Combinator batch Not disclosed Y Combinator YC data
Undated Seed $125,000 Not disclosed Database
Jun 12, 2023 Seed $3.2M General Catalyst (lead); Y Combinator; Wayfinder Ventures; Andrew Adams of Headway; Divya Bhatt of Virta Independent
Undated Series A Not disclosed Not disclosed; company names General Catalyst as backer Company-stated

What the filings show

Finni Health · Form D · none on file

Offerings found
None under Finni Health or Journey Health Technologies U.S. Inc.
Mentions
No EDGAR Form D from any investment vehicle naming the company
What that means
An issuer raising under Section 4(a)(2) rather than Regulation D files no Form D, so the absence does not prove no money moved
Record pulled
Sep 24, 2026

Journey Health Technologies U.S. Inc. · NPPES enrollment · May 6, 2022

NPI
1528704236, type 2 organization
Trade name
Finni Health, filed as a doing business as
Primary taxonomy
Behavior Analyst, 103K00000X, within a Multi-Specialty Group
Other taxonomies
Day Training, Developmentally Disabled Services; Community/Behavioral Health
Authorized official
Yilun Chen, chief technology officer
Locations
Six, in New Mexico, Colorado, Ohio (two), Tennessee and Idaho
Last certified
Sep 15, 2026

Reading the record

  1. No Form D at all.The seed was announced publicly in June 2023 by the company, by its law firm and by two trade outlets, and no Regulation D notice corresponds to it. A Delaware or Canadian issuer selling to a small number of accredited investors under Section 4(a)(2) has no filing duty. The practical effect is that every capital number on this page comes from the company or from a database, not from the SEC.
  2. The announced capital is small against the described footprint.$3.2 million divided by the 45 active practices the recruiting page claims is about $71,000 of disclosed equity per practice. Divided by the 27 credentialed clinical leads in the public directory it is about $119,000 each. Neither figure covers the working capital a credentialing and billing business normally fronts, which suggests either undisclosed capital, revenue financing, or a lighter model than the marketing implies.
  3. Tracxn’s total leaves about $750,000 unaccounted.Tracxn reports $3.95 million across four rounds and labels all four seed. Subtract the $3.2 million announced and roughly $750,000 sits in earlier or smaller rounds, one of which Dealroom records as $125,000. None of it is filed.
  4. A Series A is asserted, not announced.The careers page carries a “Series A” label and names General Catalyst as backer. Dealroom lists a Series A row with the amount blank. There is no press release, no lead investor, no date and no Form D. Until one of those appears, the round exists only as a recruiting signal.
  5. Revenue figures are third party estimates.The founders stated $30,000 in monthly revenue in early 2023. GetLatka publishes $10.4 million for 2024 and marks it an estimate from its own model. If the estimate were right, the company would have built roughly two and a half times its lifetime disclosed capital in annual revenue, which is the kind of claim that normally gets audited before it gets repeated.
  6. The billing entity is the asset.Capital aside, the durable thing on the public record is the provider enrollment: one organizational NPI, a Behavior Analyst taxonomy and six listed locations. Payer contracts attach to that entity, not to the software.

Commercial signals

Signal Detail Source type
Provider status Enrolled organizational NPI since May 2022, certified Sep 2026, six locations in five states. Public record
States served Recruiting page says 35 or more; careers page says 21 or more; the public directory shows 23. Company sources disagree
Payer breadth “Backed by 11+ major insurances,” unnamed. Directory entries list Medicaid, Optum, Blue Cross Blue Shield, Aetna, UnitedHealthcare and Priority Health for one Michigan practice. Company-stated
Clinical staffing 27 named leads in the directory hold BCBA, BCBA-D or state licensed behavior analyst credentials. Company directory
Sector risk HHS Office of Inspector General found at least $56 million in improper Indiana Medicaid ABA payments and $18.5 million in Wisconsin. State utilization limits are tightening. Public record
Competitive setting Private equity acquired 574 autism service sites through 147 deals across 42 states from 2015 to 2024. Independent

What to watch

  • A Form D, which would be due within 15 days of a first sale if any round is taken under Regulation D.
  • A Series A announcement with an amount, a date and a lead.
  • Additional NPI enrollments or state entity registrations as the practice count grows.
  • State Medicaid rate and hour limits, which set the revenue ceiling for every practice on the platform.
  • Any audited or payer verified figure replacing the website percentages.

The Finni Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Breathe Well-being: Shared investor: General Catalyst. A New Delhi area program that coaches people with Type 2 diabetes off medication by phone and through a mobile app
  • Ophelia: Shared investor: General Catalyst. A telehealth medical practice treating opioid use disorder with medication and a care team
  • Lucis: Shared investor: General Catalyst. A Paris-based subscription that turns a blood draw at a partner lab into an AI-read dashboard of biomarkers, pitched as “Function Health for Europe.” Founded in 2025, it
  • Ribbon Health: Shared investor: General Catalyst. An API built to answer a question the American health system keeps getting wrong: is this doctor real, in network, and reachable at the number listed

Sources

  1. Public recordNPPES NPI record 1528704236, Journey Health Technologies U.S. Inc.CMS · Sep 15, 2026
  2. Public recordSEC EDGAR Form D search, issuer and mention sweepCompiled · Sep 24, 2026
  3. IndependentFinni Health raises $3.2M to improve access to autism careHIT Consultant · Jun 12, 2023
  4. IndependentFinni Health: $3.2 million raisedPulse 2.0 · Jun 15, 2023
  5. IndependentFinni Health seed financing, representative workOsler, Hoskin & Harcourt LLP
  6. DatabaseFinni Health funding rounds and investorsTracxn · accessed Sep 2026
  7. DatabaseFinni Health company recordDealroom · accessed Sep 2026
  8. DatabaseFinni Health revenue estimateGetLatka · accessed Sep 2026
  9. IndependentPrivate equity acquired nearly 600 autism therapy sitesAcuity News · Feb 11, 2026
  10. IndependentABA under payment scrutiny, on the HHS OIG auditsMorgan Lewis · Nov 14, 2025
  11. CompanyFinni Health raises $3.2MFinni Health · Jun 12, 2023
  12. CompanyRecruiting, careers and provider directory pagesFinni Health · Sep 24, 2026
  13. CompanyLaunch YC: Finni HealthY Combinator · Winter 2023

Compiled from SEC, CMS and other public records and published reports as of September 24, 2026. Form D notices report offerings under Regulation D; no such notice was found for this company, and issuers relying on Section 4(a)(2) file none. Healthcare Venture Capital Fund holds no position in Finni Health. This page is not an offer to sell or a recommendation to buy any security.